| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |